Bosnalijek d.d. Sarajevo Logo

Bosnalijek d.d. Sarajevo

Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.

BSNL | SASE

Overview

Corporate Details

ISIN(s):
BABSNLR00005
LEI:
Country:
Bosnia and Herzegovina
Address:
Jukićeva 53, 71000 Sarajevo
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1951, Bosnalijek is a major industrial manufacturer of pharmaceuticals. The company develops and produces a wide portfolio of high-quality medications for peroral, parenteral, and topical applications, targeting conditions related to the digestive system, metabolism, and cardiovascular system. With a presence in more than 20 international markets, Bosnalijek's quality assurance system adheres to stringent national and international Good Manufacturing Practice (GMP) standards. The company's strategy is centered on modernizing its facilities, advancing knowledge, and investing in new technologies to drive innovation within the industry.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Bosnalijek d.d. Sarajevo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bosnalijek d.d. Sarajevo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bosnalijek d.d. Sarajevo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France
ABVX
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France
ABLD
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD

Talk to a Data Expert

Have a question? We'll get back to you promptly.